design, setting, participants, & measurements individuals with stage 4 (egfr, 15â€“29 ml/min per 1.73 m2) ckd due to hypertensive nephropathy, had a ptco2 level < 22 mm, and were receiving angiotensin-converting enzyme inhibition were randomly assigned to 1 year of daily oral nahco3 at 1.0 meq/kg per day (n=35) or fruits and vegetables dosed to reduce dietary acid by half (n=36).